• Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
Search
Medicines Law & Policy Research and resources on intellectual property and health
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About

Ellen 't Hoen

51 POSTS 0 COMMENTS
http://medicineslawandpolicy.org

TRIPS, technology transfer and access to pandemic countermeasures: What the WHO  Pandemic Treaty must...

Ellen 't Hoen - October 7, 2022

Wrapping up 2021 – some noteworthy medicines law and policy events

Ellen 't Hoen - December 24, 2021

Imagine if health and trade ministers would meet in one room this week

Ellen 't Hoen - November 30, 2021

Vaccine knowledge needs to be a global public good: Remarks to the World Trade...

Ellen 't Hoen - July 22, 2021

Covid shows the world it needs new rules to deal with pandemics

Ellen 't Hoen - May 21, 2021

Dutch Health Care Institute Says No to Medicines Pirate

Ellen 't Hoen - March 29, 2021

The elephant in the room at the WHO Executive Board

Ellen 't Hoen - January 22, 2021

Some Surprises in the European Commission’s New Intellectual Property Strategy

Ellen 't Hoen - December 2, 2020

Dutch Court Orders AstraZeneca to Pay Damages in Patent Evergreening Case

Ellen 't Hoen - October 14, 2020

WTO Members discuss proposal to suspend certain intellectual property protection during the Covid-19 crisis

Ellen 't Hoen - October 14, 2020
123...6Page 1 of 6
Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
 This work is licensed under Creative Commons.